🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

JPMorgan raises IBM shares target citing strong software sales

EditorEmilio Ghigini
Published 07/25/2024, 05:43 AM
IBM
-

On Thursday, JPMorgan updated its stance on IBM (NYSE:IBM) shares, increasing the price target to $190 from $185, while maintaining a Neutral rating. The firm's analyst cited IBM's earnings per share (EPS) beat and upward revision to its fiscal year 2024 free cash flow (FCF) guidance as key factors behind the adjustment.

IBM's recent quarterly results showcased a continuation of robust software growth, notably from its Red Hat and Automation segments, alongside solid non-GAAP earnings and cash flow.

IBM's software performance, particularly the growth of Red Hat, although slightly decelerated this quarter, still supports management's confidence in a potential acceleration later in the year. The company's Transaction Processing and Infrastructure revenues also surpassed expectations.

Despite a slight concern over Red Hat's slower growth, bookings and a six-month remaining performance obligations (RPO) growth in the teens are seen as reassuring signs.

For the remainder of the year, IBM's total revenue guidance remains unchanged, with anticipated growth at the lower end of the previously stated range. However, the company expects a shift in the mix of growth towards the software sector, with consulting growth projected to decline through year-end. The analyst views the increasing strength of IBM's software business as beneficial for the company's overall valuation.

IBM's growing portfolio in the GenAI business, which has reached $2 billion since its inception, is also contributing to the company's positive outlook. The mix of consulting and software services in this area is approximately 75/25.

IBM's approach to utilizing more efficient and cost-effective discrete models aligns well with its platform capabilities. Additionally, the company has raised its FCF guidance for fiscal year 2024 to over $12 billion, up from the previously stated $12 billion.

The firm also noted IBM's positive macro commentary, indicating that technology spending remains strong despite certain factors, such as interest rates, influencing the timing of decisions and discretionary consulting spending.

The anticipated completion of the sale of IBM's QRadar SaaS assets in the third quarter and the expected closure of the HashiCorp (NASDAQ:HCP) deal by year-end were also mentioned as positive developments. With these considerations, JPMorgan has revised its price target to reflect IBM's improved performance and outlook.

In other recent news, IBM has exceeded Q2 2024 expectations, displaying a strong performance largely due to its focus on software and infrastructure, specifically within its hybrid cloud and AI segments.

The company reported a robust revenue of $15.8 billion and operating diluted earnings per share of $2.43. The success of IBM's AI strategy, which includes the open-sourcing of its Granite family of models, has been reflected across all segments.

Notably, IBM's operating gross margin and operating pre-tax margin have expanded, with free cash flow reaching a multi-year high of $4.5 billion for the first half of the year. The company's balance sheet remains robust with $16 billion in cash, and IBM has returned $3.1 billion to shareholders through dividends.

These developments are recent and underscore the company's strong financial health and growth trajectory. IBM's full-year constant-currency revenue growth is projected to align with the mid-single-digit model and free cash flow is expected to exceed $12 billion.

InvestingPro Insights

Following JPMorgan's updated stance on IBM, an analysis of real-time data from InvestingPro provides a deeper insight into the company's financial health and market position. IBM's market capitalization stands at a robust $169.04 billion, reflecting the company's significant presence in the industry. The company trades at a Price/Earnings (P/E) ratio of 20.01, which is aligned with the industry's standards, considering its stable business model and consistent performance. Moreover, IBM's Price/Book ratio as of the last twelve months is 7.27, highlighting a premium valuation that investors are willing to pay for its equity, likely due to IBM's long-standing reputation and solid balance sheet.

IBM's dividend yield is currently an attractive 3.63%, which is particularly noteworthy for income-seeking investors. This is supported by the company's impressive track record of maintaining dividend payments for 54 consecutive years, as highlighted in one of the InvestingPro Tips. Additionally, IBM's stock is known for its low price volatility, providing a sense of stability for long-term investors. With the company's year-to-date price total return at 14.67%, IBM has shown a strong performance in the market, further solidifying its appeal to shareholders.

InvestingPro offers additional insights and tips for IBM, including predictions on profitability and market trends. For those interested in gaining a comprehensive understanding of IBM's investment potential, accessing these additional tips can be invaluable. Use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription at InvestingPro. With 7 more InvestingPro Tips available, investors can make well-informed decisions backed by expert analysis and real-time data.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.